Tics Induced by Mirtazapine in an Adolescent.

IF 2.4 4区医学 Q3 NEUROSCIENCES

Clinical Psychopharmacology and Neuroscience Pub Date : 2025-05-31 Epub Date: 2024-10-10 DOI:10.9758/cpn.24.1211

Senem Yapar, Nurullah Bolat

引用次数: 0

Abstract

Mirtazapine is an antidepressant approved by the FDA whose mechanism of action involves antagonism of alpha-2, H1, 5-HT2A, 5-HT2C, and 5-HT3 receptors. Tics are sudden, rapid, purposeless, recurrent, non-rhythmic motor movements or vocalizations. There have been previous case reports of various medications causing tics. In this article, we report tic symptoms that we thought developed in association with mirtazapine treatment.

查看原文本刊更多论文

米氮平致青少年抽搐。

米氮平是FDA批准的抗抑郁药，其作用机制涉及α -2、H1、5-HT2A、5-HT2C和5-HT3受体的拮抗作用。抽搐是突然的、快速的、无目的的、反复的、无节奏的运动或发声。以前有各种药物引起抽搐的病例报告。在这篇文章中，我们报告了抽搐症状，我们认为这些症状与米氮平治疗有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Psychopharmacology and Neuroscience NEUROSCIENCESPHARMACOLOGY & PHARMACY-PHARMACOLOGY & PHARMACY

CiteScore

4.70

自引率

12.50%

发文量

期刊介绍： Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of Neuropsychopharmacology (KCNP), and the associate journal for Asian College of Neuropsychopharmacology (AsCNP). This journal aims to publish evidence-based, scientifically written articles related to clinical and preclinical studies in the field of psychopharmacology and neuroscience. This journal intends to foster and encourage communications between psychiatrist, neuroscientist and all related experts in Asia as well as worldwide. It is published four times a year at the last day of February, May, August, and November.